Fluconazole

氟康唑

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameFluconazole
Drug Alias Name大扶康Fluconazolum氟可那挫FluconazolTriflucan +[12] 
ClassificationSmall molecules > Heterocyclic drugs > Antifungals
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsMouth DiseasesHead and Neck NeoplasmsHIV Infections +[16] 
Global Approved IndicationsMycoses
Approved Indications in ChinaMycoses
Original Approved Country/TerritoryJapan
Original Approved Date1989/03/31
Country/TerritoryBelgiumBulgariaCanada +[26] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesMaastricht University Medical CenterBasilea PharmaceuticaPfizer Inc +[5] 
Inactive CompaniesEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentShanghai Jiao Tong University School of MedicineSutphin Drugs Inc +[8] 
Active IndicationsMeningitis, CryptococcalCandidiasis, VulvovaginalCandidiasis, Oral +[6] 
Inactive IndicationsMouth DiseasesHead and Neck NeoplasmsHIV Infections +[10] 

Other Information

ATC CodeD01AC15J02AC01
Related LinksWikipediaDrugBankKEGG